by Erica Moser,University of PennsylvaniaCredit: Abdallah ChilungoWith 9.5% of its population estimated to be HIV-positive in 2019, Malawi has one of the highest rates of HIV prevalence in the world.
by Erica Moser,University of PennsylvaniaCredit: Abdallah ChilungoWith 9.5% of its population estimated to be HIV-positive in 2019, Malawi has one of the highest rates of HIV prevalence in the world.
byThe City University of New YorkCredit: Unsplash/CC0 Public DomainIn an articlepublishedinThe Lancet HIV, authors including Distinguished Professor Denis Nash and Professor Constantin Yiannoutsos aim
byThe City University of New YorkCredit: Unsplash/CC0 Public DomainIn an articlepublishedinThe Lancet HIV, authors including Distinguished Professor Denis Nash and Professor Constantin Yiannoutsos aim
by Jeff Renaud,University of Western OntarioHIV-1 LTR heterogeneity at the TBC1D5 integration site hotspot. Credit:Communications Medicine(2025). DOI: 10.1038/s43856-025-01146-5Researchers at Western
by Jeff Renaud,University of Western OntarioHIV-1 LTR heterogeneity at the TBC1D5 integration site hotspot. Credit:Communications Medicine(2025). DOI: 10.1038/s43856-025-01146-5Researchers at Western
byDelthia Ricks, Medical XpressCredit: CC0 Public DomainDespite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human immunodeficiency virus
byDelthia Ricks, Medical XpressCredit: CC0 Public DomainDespite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human immunodeficiency virus
byWits UniversityCredit: Unsplash/CC0 Public DomainHIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment interventions are actually working
byWits UniversityCredit: Unsplash/CC0 Public DomainHIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment interventions are actually working